Contributions of multimodal imaging

gan Oyen, Wim JG
Cyhoeddwyd yn Cancer Imaging (2014)

Consensus Procedures in Oncological Imaging: The Case of Prostate Cancer

gan Fanti, Stefano, Oyen, Wim, Lalumera, Elisabetta
Cyhoeddwyd yn Cancers (Basel) (2019)

FIAU: From reporter gene imaging to imaging of bacterial proliferation

gan Boerman, Otto C, Laverman, Peter, Oyen, Wim JG
Cyhoeddwyd 2012

Predictive and prognostic value of FDG-PET

gan de Geus-Oei, Lioe-Fee, Oyen, Wim J.G.
Cyhoeddwyd 2008

Nuclear medicine imaging and therapy of neuroendocrine tumours

gan Gotthardt, Martin, Dijkgraaf, Ingrid, Boerman, Otto C, Oyen, Wim J G
Cyhoeddwyd 2006

Gastroparesis in patients with inactive Crohn's disease: a case series

gan Kristinsson, Jón O, Hopman, Wim PM, Oyen, Wim JG, Drenth, Joost PH
Cyhoeddwyd 2007

Improved labelling of DTPA- and DOTA-conjugated peptides and antibodies with (111)In in HEPES and MES buffer

gan Brom, Maarten, Joosten, Lieke, Oyen, Wim JG, Gotthardt, Martin, Boerman, Otto C
Cyhoeddwyd 2012

Radiolabelled peptides for oncological diagnosis

gan Laverman, Peter, Sosabowski, Jane K., Boerman, Otto C., Oyen, Wim J. G.
Cyhoeddwyd 2012

Peritoneal Carcinomatosis of Colorectal Origin: Incidence and Current Treatment Strategies

gan Koppe, Manuel J., Boerman, Otto C., Oyen, Wim J. G., Bleichrodt, Robert P.
Cyhoeddwyd 2006

Peritoneal Carcinomatosis of Colorectal Origin: Standard of Care

gan Koppe, Manuel J., Boerman, Otto C., Oyen, Wim J. G., Bleichrodt, Robert P.
Cyhoeddwyd 2006

(68)Ga-labelled exendin-3, a new agent for the detection of insulinomas with PET

gan Brom, Maarten, Oyen, Wim J. G., Joosten, Lieke, Gotthardt, Martin, Boerman, Otto C.
Cyhoeddwyd 2010

Radiolabelled GLP-1 analogues for in vivo targeting of insulinomas

gan Brom, Maarten, Joosten, Lieke, Oyen, Wim J.G., Gotthardt, Martin, Boerman, Otto C.
Cyhoeddwyd yn Contrast Media Mol Imaging (2012)

FDG-PET/CT in a Patient with Poor-Risk Non-Seminoma Testis with Mature Teratoma and Secondary Gliosarcoma: Multimodality Imaging for Guiding Multimodality Treatment

gan Quak, Elske, Kovacs, Iringo, Oyen, Wim J. G., van der Graaf, Winette T. A.
Cyhoeddwyd yn Nucl Med Mol Imaging (2015)

Methodological considerations in quantification of oncological FDG PET studies

gan Vriens, Dennis, Visser, Eric P., de Geus-Oei, Lioe-Fee, Oyen, Wim J. G.
Cyhoeddwyd 2009

Multi-modality nuclear medicine imaging: artefacts, pitfalls and recommendations

gan van Dalen, Jorn A., Vogel, Wouter V., Corstens, Frans H.M., Oyen, Wim J.G.
Cyhoeddwyd 2007

Can FDG PET predict radiation treatment outcome in head and neck cancer? Results of a prospective study

gan Schinagl, Dominic A. X., Span, Paul N., Oyen, Wim J., Kaanders, Johannes H. A. M.
Cyhoeddwyd 2011

Immunotherapy response evaluation with (18)F-FDG-PET in patients with advanced stage renal cell carcinoma

gan Gilles, Rozemarie, de Geus-Oei, Lioe-Fee, Mulders, Peter F. A., Oyen, Wim J. G.
Cyhoeddwyd 2011

EANM/EARL FDG-PET/CT accreditation - summary results from the first 200 accredited imaging systems

gan Kaalep, Andres, Sera, Terez, Oyen, Wim, Krause, Bernd J., Chiti, Arturo, Liu, Yan, Boellaard, Ronald
Cyhoeddwyd yn Eur J Nucl Med Mol Imaging (2017)

Radiolabeled antibodies in renal cell carcinoma

gan Stillebroer, Alexander B., Oosterwijk, Egbert, Oyen, Wim J.G., Mulders, Peter F.A., Boerman, Otto C.
Cyhoeddwyd 2007

Antibody therapy in renal cell carcinoma

gan Oosterwijk, Egbert, Boerman, Otto C., Oyen, Wim J. C., Old, Lloyd J., Mulders, Peter F. A.
Cyhoeddwyd 2008